News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,048 Results
Type
Article (14546)
Company Profile (74)
Press Release (304425)
Multimedia
Podcasts (42)
Webinars (7)
Section
Business (87338)
Career Advice (454)
Deals (18083)
Drug Delivery (45)
Drug Development (48774)
Employer Resources (52)
FDA (8132)
Job Trends (6788)
News (161774)
Policy (14234)
Tag
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (898)
Accelerated approval (23)
Adcomms (19)
Allergies (74)
Alliances (22195)
ALS (83)
Alzheimer's disease (826)
Antibody-drug conjugate (ADC) (285)
Approvals (8436)
Artificial intelligence (314)
Autoimmune disease (105)
Automation (13)
Bankruptcy (162)
Best Places to Work (6109)
BIOSECURE Act (3)
Biosimilars (111)
Biotechnology (64)
Bladder cancer (151)
Brain cancer (54)
Breast cancer (565)
Cancer (4282)
Cardiovascular disease (206)
Career advice (403)
Career pathing (11)
CAR-T (234)
CDC (12)
Celiac Disease (1)
Cell therapy (533)
Cervical cancer (29)
Clinical research (43573)
Collaboration (1085)
Company closure (2)
Compensation (375)
Complete response letters (27)
COVID-19 (1100)
CRISPR (50)
C-suite (498)
Cystic fibrosis (74)
Data (4702)
Decentralized trials (1)
Denatured (10)
Depression (67)
Diabetes (219)
Diagnostics (3295)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (26)
Drug discovery (152)
Drug pricing (84)
Drug shortages (19)
Duchenne muscular dystrophy (133)
Earnings (41897)
Editorial (32)
Employer branding (7)
Employer resources (48)
Events (49580)
Executive appointments (534)
FDA (10319)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (784)
Gene editing (112)
Generative AI (29)
Gene therapy (311)
GLP-1 (413)
Government (1661)
Grass and pollen (2)
Guidances (312)
Healthcare (8769)
HIV (41)
Huntington's disease (18)
IgA nephropathy (65)
Immunology and inflammation (135)
Immuno-oncology (60)
Indications (86)
Infectious disease (1246)
Inflammatory bowel disease (104)
Inflation Reduction Act (8)
Influenza (59)
Intellectual property (181)
Interviews (74)
IPO (9551)
IRA (29)
Job creations (991)
Job search strategy (331)
JPM (30)
Kidney cancer (17)
Labor market (25)
Layoffs (178)
Leadership (13)
Legal (2423)
Liver cancer (80)
Longevity (3)
Lung cancer (583)
Lymphoma (321)
Machine learning (26)
Management (12)
Manufacturing (378)
MASH (108)
Medical device (5428)
Medtech (5454)
Mergers & acquisitions (9303)
Metabolic disorders (619)
Multiple sclerosis (96)
NASH (10)
Neurodegenerative disease (135)
Neuropsychiatric disorders (40)
Neuroscience (1454)
NextGen: Class of 2026 (2273)
Non-profit (1247)
Now hiring (18)
Obesity (285)
Opinion (139)
Ovarian cancer (155)
Pain (112)
Pancreatic cancer (204)
Parkinson's disease (130)
Partnered (12)
Patents (344)
Patient recruitment (370)
Peanut (19)
People (24688)
Pharmaceutical (18)
Pharmacy benefit managers (12)
Phase 1 (14344)
Phase 2 (19109)
Phase 3 (14336)
Pipeline (3941)
Policy (111)
Postmarket research (1100)
Preclinical (5161)
Press Release (11)
Prostate cancer (206)
Psychedelics (16)
Radiopharmaceuticals (232)
Rare diseases (471)
Real estate (1654)
Recruiting (16)
Regulatory (12802)
Reports (25)
Research institute (1121)
Resumes & cover letters (59)
Rett syndrome (22)
RNA editing (8)
RSV (41)
Schizophrenia (89)
Series A (136)
Series B (99)
Service/supplier (3)
Sickle cell disease (66)
Special edition (5)
Spinal muscular atrophy (51)
Sponsored (21)
Startups (1306)
State (1)
Stomach cancer (13)
Supply chain (50)
Tariffs (24)
The Weekly (31)
Vaccines (458)
Venture capital (46)
Weight loss (162)
Women's health (31)
Worklife (5)
Date
Today (125)
Last 7 days (373)
Last 30 days (1304)
Last 365 days (19110)
2026 (2122)
2025 (19080)
2024 (21587)
2023 (24353)
2022 (29221)
2021 (30634)
2020 (27975)
2019 (20073)
2018 (14961)
2017 (16061)
2016 (14019)
2015 (16363)
2014 (11248)
2013 (8107)
2012 (8500)
2011 (9157)
2010 (8342)
Location
Africa (274)
Alabama (44)
Alaska (4)
Arizona (92)
Arkansas (4)
Asia (23759)
Australia (5433)
California (7190)
Canada (2166)
China (818)
Colorado (260)
Connecticut (333)
Delaware (268)
Europe (43376)
Florida (1087)
Georgia (129)
Hawaii (1)
Idaho (13)
Illinois (512)
India (54)
Indiana (248)
Iowa (10)
Japan (323)
Kansas (32)
Kentucky (20)
Louisiana (11)
Maine (48)
Maryland (777)
Massachusetts (5071)
Michigan (115)
Minnesota (271)
Missouri (75)
Montana (20)
Nebraska (9)
Nevada (85)
New Hampshire (51)
New Jersey (2162)
New Mexico (8)
New York (1968)
North Carolina (735)
North Dakota (2)
Northern California (3589)
Ohio (164)
Oklahoma (3)
Oregon (12)
Pennsylvania (1345)
Puerto Rico (13)
Rhode Island (13)
South America (409)
South Carolina (45)
Southern California (2860)
Tennessee (102)
Texas (1125)
United States (24675)
Utah (173)
Virginia (150)
Washington D.C. (28)
Washington State (653)
West Virginia (2)
Wisconsin (52)
Wyoming (1)
319,048 Results for "race oncology limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
$207B Market Shift: The Race for Fast Track Approval in Oncology
February 5, 2026
·
10 min read
Press Releases
NK Cell Therapeutics Autologous vs. Allogeneic: Who Will Lead the Race to Commercialization? - Commentary by Unexakorea
February 6, 2026
·
1 min read
Business
JPM26: Pfizer Fast-Tracks Obesity Programs in Race Against Patent Cliff
Facing the loss of exclusivity on key products, Pfizer has pulled forward its lead obesity asset into Phase III and targeted a 2028 launch. CEO Albert Bourla explained the pharma’s strategy at J.P. Morgan on Monday.
January 13, 2026
·
3 min read
·
Nick Paul Taylor
GLP-1
Novo’s Wegovy Pill Wins Obesity Approval, Securing Lead in Oral GLP-1 Race
Analysts called the approval a much-needed win for Novo Nordisk, but warned that the company could struggle to grow sales once rival drugs come to market.
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)
January 7, 2026
·
2 min read
Cancer
Kura Posts New Data, Secures NDA Acceptance in Acute Myeloid Leukemia Race With Syndax
Kura Oncology won FDA priority review for its drug the day before announcing new data at ASCO 2025 showing remission in about one-quarter of patients.
June 3, 2025
·
1 min read
·
Dan Samorodnitsky
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses the emerging geopolitical battle for AI supremacy and global AI governance with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.
August 7, 2025
·
1 min read
·
Lori Ellis
Podcast
Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations
Closely watched data from Eli Lilly and Viking Therapeutics this month have reignited the discussion around oral weight-loss drugs—and their ultimate place within the anti-obesity medication market.
August 26, 2025
·
1 min read
·
Jef Akst
Neuroscience
Takeda Establishes Lead in Narcolepsy Race With Back-to-Back Phase III Wins
Takeda’s oveporexton improved wakefulness, attention and other key narcolepsy endpoints “with a high degree of statistical significance,” according to Jefferies analysts.
July 14, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH ECLIPSEBIO
Why Countries Are Racing To Build mRNA Factories While America Hesitates on Next-Gen Vaccines
In this episode presented by Eclipsebio, BioSpace’s head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines and Pad Chivukula of Arcturus Therapeutics.
July 22, 2025
·
1 min read
·
Lori Ellis
1 of 31,905
Next
